GRIN Genes Roundtable – Jan 2021
Share This Post
GRIN Genes Research Roundtable Summary
CureGRIN Foundation hosted our fourth GRIN Genes Roundtable on January 21, 2021. Our goal is to promote collaboration so that we can accelerate the path to treatments and cures for GRIN Disorder.
We brought together researchers and clinicians studying GRIN Disorder, GRIN genes, NMDA receptors, and other ionotropic receptors to discuss and exchange ideas on clinical trials. There were 55 participants present for the meeting.
We asked Paul Wasielewski to share his family story regarding his son Austin. Additionally, a panel of five researchers and clinicians presented on their work related to GRIN treatments and clinical trials. Following the presentations, we also had an open discussion on this topic. This document summarizes these presentations and the group discussion.
Our next GRIN Genes Research Roundtable is scheduled for Thursday, March 4, 2021 where we will have an open discussion on the topic of GRIN Research Priorities. If you are a GRIN / NMDA researcher or clinician, please feel free to reach out to meagan@curegrin.org to be added to the next meeting invitation.
Read more Posts
Radiprodil reduces seizures in GRIN (gain-of-function) patients by a median of 86% in first-ever commercial clinical trial for GRI Disorders
The potential treatment also led to clinical improvements in other symptoms, and was well tolerated from a safety perspective.
2022 GRI Conference
GRI Conference brings together GRI families, researchers and clinicians, and industry representatives from around the world to educate, collaborate and network for treatments and cures for GRI Disorders.
